These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure. Dickstein K J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558 [TBL] [Abstract][Full Text] [Related]
24. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats. Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130 [TBL] [Abstract][Full Text] [Related]
25. Abolition of long-term vascular influence of renin-angiotensin system. Randall RD; Zimmerman BG Am J Physiol; 1990 Aug; 259(2 Pt 2):H543-53. PubMed ID: 2167025 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography. Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA Hypertension; 1988 Mar; 11(3):230-8. PubMed ID: 2832327 [TBL] [Abstract][Full Text] [Related]
27. Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats. Tomlinson KC; Gardiner SM; Bennett T J Cardiovasc Pharmacol; 1990 Apr; 15(4):562-8. PubMed ID: 1691384 [TBL] [Abstract][Full Text] [Related]
28. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme. Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812 [TBL] [Abstract][Full Text] [Related]
30. Experience with perindopril in normal volunteers. Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899 [TBL] [Abstract][Full Text] [Related]
31. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit. Zhuo J; Casley D; Murone C; Mendelsohn FA J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666 [TBL] [Abstract][Full Text] [Related]
32. Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension. Karlberg BE; Rosenqvist U Acta Med Scand Suppl; 1986; 714():33-42. PubMed ID: 3033998 [TBL] [Abstract][Full Text] [Related]
33. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307 [TBL] [Abstract][Full Text] [Related]
35. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884 [TBL] [Abstract][Full Text] [Related]
36. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension. Wallis EJ; Ramsay LE; Hettiarachchi J Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801 [TBL] [Abstract][Full Text] [Related]
37. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin(1-7) in the spontaneously hypertensive rat. Kohara K; Brosnihan KB; Ferrario CM Peptides; 1993; 14(5):883-91. PubMed ID: 8284265 [TBL] [Abstract][Full Text] [Related]
39. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046 [TBL] [Abstract][Full Text] [Related]
40. Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats. Oparil S; Narkates AJ; Jackson RM; Ann HS J Appl Physiol (1985); 1988 Jul; 65(1):218-27. PubMed ID: 2841276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]